Statins Post-PCI: Moderate-Intensity and Add Ezetimibe?
Jul 25, 2023 · RACING concluded that ezetimibe plus a moderate-intensity statin could be as effective as a high-intensity statin in patients with CV disease, "but have fewer side effects and better compliance ...
New Cholesterol Guidelines Abandon LDL Targets - Medscape
Nov 14, 2013 · For those with diabetes aged 40 to 75 years of age, a moderate-intensity statin, defined as a drug that lowers LDL cholesterol 30% to 49%, should be used, whereas a high-intensity statin is a ...
Statins Raise Diabetes Risk, but CV Benefit Outweighs It - Medscape
Apr 9, 2024 · In the statin vs placebo trials, differences in A1c values from placebo were 0.06 percentage points higher for low- or moderate-intensity statins and 0.08 points greater for high-intensity statins.
'Conservative' USPSTF Primary Prevention Statin Guidance Finalized
Aug 24, 2022 · The USPSTF guidance applies only to adults aged 40-75 without CV signs or symptoms and recommends a statin prescription for persons at "high risk," that is with an estimated 10-year PCE-based risk ...
Statin Response Varies by Age - Medscape
Jul 31, 2023 · 12% were age 75 or older, and 16% were younger than 50 years. With 20 mg of simvastatin, the older group had a greater percentage reduction in low-density lipoprotein cholesterol (LDL-C) than did ...
USPSTF Tweaks Statin Recommendations in New Draft Guidance
Feb 22, 2022 · A new draft guidance from the US Preventive Services Task Force uses more recent data to update its 2016 document on when to consider moderate-intensity statin therapy for primary prevention.
High-Intensity Statins Underused After CHD Events: Analysis
Jan 20, 2015 · In the look-back period, 16.8% of beneficiaries had filled a high-intensity statin prescription, 53.1% had filled a low- to moderate-intensity statin prescription, while 30.1% had no statin fills.
Treat-to-Target or High-Intensity Statin in Clinical CAD? - Medscape
Mar 20, 2023 · Levels of LDL-C 70 mg/dL or lower were achieved within 3 months by 59.2% in the treat-to-target group and 67.3% of patients in the high-intensity statin group ( = .02). With the two groups ...
LAPLACE-2: The Place of Evolocumab in the Age of Statins?
Apr 23, 2014 · Those who received a moderate-intensity statin started out with a little bit lower LDL-C level than the high-intensity group, but at the end of the day, both groups achieved a fairly similar LDL-C ...
Ezetimibe Plus Statin: Attractive Bypass to - Medscape
Jul 28, 2022 · The open-label study, dubbed RACING, randomized 3780 patients with ASCVD to receive moderate-intensity rosuvastatin 10 mg plus ezetimibe 10 mg or high-intensity 20 mg rosuvastatin monotherapy ...